相关实验视频

Updated: May 24, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

胺最近的发展添加了HIV-1非核酸逆转录酶抑制剂

S Maheen Abdul Rahman¹, Gurpreet Singh², Mhd Shabbu Khan¹

¹Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, VPO-Ghudda, Bathinda 151401, Punjab, India.

Bioorganic chemistry

|March 4, 2025

概括

基于皮里米丁的药物对于治疗获得性免疫缺陷综合征 (艾滋病) 是至关重要的. 本综述强调了设计强效非核酸逆转录酶抑制剂 (NNRTIs) 应对抗药物耐药的人类免疫缺陷病毒 (HIV-1) 的最新进展.

科学领域:

药用化学医学化学
病毒学病毒学
药物发现药物发现药物发现

背景情况:

由人类免疫缺陷病毒 (HIV-1) 引起的获得性免疫缺陷综合征 (AIDS) 仍然是全球健康威胁,需要新的治疗策略.
反转录酶 (RT) 是HIV-1复制的关键酶,也是抗病毒药物开发的主要标.
现有的非核类逆转录酶抑制剂 (NNRTIs) 面临着由于新兴药物耐药性和低于最佳的药理动力学的挑战.

研究的目的:

综合审查最近设计和开发用于HIV-1治疗的基于pyrimidine的非核酸逆转录酶抑制剂 (NNRTIs) 的进展.
探索新型胺基衍生物的结构-活性关系和生物活动.
讨论X射线结晶学和分子建模在指导合理药物设计中的作用.

主要方法:

文献综述,重点关注以胺为基础的NNRTIs的最新研究趋势.
分析结构-活动关系 (SAR),以了解分子相互作用.
包括对接研究的数据来预测绑定亲和关系和指导设计.

主要成果:

在设计替代胺素作为强效和选择性的NNRTI方面取得了重大进展.
通过合理的设计策略,通过合理的设计策略来实现更好的耐药性和药物动力学特性.
X射线结晶学和分子建模加速了基于pyrimidine的有效HIV-1抑制剂的发现.

结论:

胺基支架是开发下一代抗HIV-1 NNRTIs的有希望的基础.
持续的研究整合SAR,对接和先进的结构生物学对于创造具有增强功效,安全性和有效性的药物至关重要.
这些进展为克服耐药HIV-1菌株带来的挑战提供了希望.

关键词:

艾滋病艾滋病艾滋病是什么?停靠的对接方式艾滋病病毒-1 艾滋病病毒-1 没有NNRTIs的NNRTIs 皮里米丁是什么皮里米丁是什么反转录酶抑制剂逆转录酶抑制剂病毒病毒病毒

更多相关视频

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Published on: January 19, 2015

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...